HK1206990A1 - Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole - Google Patents

Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole

Info

Publication number
HK1206990A1
HK1206990A1 HK15107666.1A HK15107666A HK1206990A1 HK 1206990 A1 HK1206990 A1 HK 1206990A1 HK 15107666 A HK15107666 A HK 15107666A HK 1206990 A1 HK1206990 A1 HK 1206990A1
Authority
HK
Hong Kong
Prior art keywords
aripiprazole
solid preparation
oral solid
producing
producing oral
Prior art date
Application number
HK15107666.1A
Other languages
English (en)
Chinese (zh)
Inventor
Haruka Yoshida
Toshiaki Taniguchi
Tadashi Mukai
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50897828&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1206990(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1206990A1 publication Critical patent/HK1206990A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15107666.1A 2013-04-30 2015-08-08 Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole HK1206990A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013095725 2013-04-30
JP2013204546 2013-09-30
PCT/JP2014/061643 WO2014178334A1 (en) 2013-04-30 2014-04-18 Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole

Publications (1)

Publication Number Publication Date
HK1206990A1 true HK1206990A1 (en) 2016-01-22

Family

ID=50897828

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107666.1A HK1206990A1 (en) 2013-04-30 2015-08-08 Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole

Country Status (11)

Country Link
EP (2) EP3187173A1 (es)
JP (1) JP5931219B2 (es)
KR (2) KR101759017B1 (es)
CN (1) CN105246461B (es)
AU (2) AU2014260863A1 (es)
CA (1) CA2910665C (es)
ES (1) ES2625613T3 (es)
HK (1) HK1206990A1 (es)
PH (1) PH12015502435A1 (es)
TW (2) TW201740947A (es)
WO (1) WO2014178334A1 (es)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2608788B2 (ja) 1988-10-31 1997-05-14 大塚製薬 株式会社 精神分裂病治療剤
CA2311734C (en) 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
AR033485A1 (es) * 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
ZA200602347B (en) * 2003-10-23 2007-09-26 Otsuka Pharma Co Ltd Controlled release sterile injectable aripiprazole formulation and method
EP2279727A3 (en) * 2005-09-15 2011-10-05 Elan Pharma International Limited Nanoparticulate aripiprazole formulations
JP2008537540A (ja) * 2005-12-22 2008-09-18 テバ ファーマシューティカル インダストリーズ リミティド アリピプラゾールの粒径を小さくする方法
CN101351192A (zh) * 2006-01-05 2009-01-21 特瓦制药工业有限公司 阿立哌唑的湿法制粒的药用组合物
TR200604349A2 (tr) * 2006-08-15 2008-03-21 NOBEL İLAÇ SANAYii VE TiCARET A.Ş. Aripiprazol içeren farmasötik bileşimler
KR100924236B1 (ko) * 2009-06-23 2009-10-29 충남대학교산학협력단 균일한 입도분포를 가지는 초미세입자의 신규한 제조방법 및 장치
CN102106807B (zh) * 2009-12-29 2013-03-27 上海中西制药有限公司 一种固体制剂的制备方法及所得固体制剂
CN102846543B (zh) * 2011-06-27 2014-11-19 上海中西制药有限公司 一种阿立哌唑药物制剂及其制备方法
CN102850268B (zh) * 2011-06-27 2015-07-15 上海中西制药有限公司 阿立哌唑ⅰ型微晶、阿立哌唑固体制剂及制备方法
TW201309651A (zh) * 2011-06-29 2013-03-01 Otsuka Pharma Co Ltd 阿立哌唑（ａｒｉｐｉｐｒａｚｏｌｅ）無水物Ｂ形結晶微粒子之製造方法

Also Published As

Publication number Publication date
CA2910665A1 (en) 2014-11-06
PH12015502435B1 (en) 2016-02-22
KR20160003136A (ko) 2016-01-08
EP2838513A1 (en) 2015-02-25
TW201740947A (zh) 2017-12-01
JP2015516942A (ja) 2015-06-18
CA2910665C (en) 2018-05-22
EP2838513B1 (en) 2017-04-05
JP5931219B2 (ja) 2016-06-08
CN105246461A (zh) 2016-01-13
KR20170052704A (ko) 2017-05-12
AU2017204483A1 (en) 2017-07-20
KR101759017B1 (ko) 2017-07-17
AU2014260863A2 (en) 2015-12-17
AU2017204483B2 (en) 2019-04-04
CN105246461B (zh) 2018-03-30
AU2014260863A1 (en) 2015-11-05
TWI624276B (zh) 2018-05-21
ES2625613T3 (es) 2017-07-20
TW201521793A (zh) 2015-06-16
EP3187173A1 (en) 2017-07-05
WO2014178334A1 (en) 2014-11-06
PH12015502435A1 (en) 2016-02-22

Similar Documents

Publication Publication Date Title
HK1221720A1 (zh) 喹唑啉衍生物及其製備方法
EP2945678A4 (en) PATIENT INTERFACE AND METHOD FOR MANUFACTURING THE SAME
EP2945680A4 (en) PATIENT INTERFACE AND METHOD FOR THE PRODUCTION THEREOF
EP3071276A4 (en) Patient interface and method for making same
EP3006415B8 (en) Method for producing nanocement and nanocement
EP3031353C0 (en) ORAL CARE SYSTEM AND PROCEDURES
SG11201500606UA (en) Patient interface and method for making same
EP2967771A4 (en) SYSTEM AND METHOD FOR PRODUCING DENTIERS
IL244285A0 (en) Methods for preparing edible preparations and edible preparations so produced
SG11201505498YA (en) Method for preparing polybutene
EP3006058A4 (en) BLOOD FILTER AND METHOD FOR THE PRODUCTION THEREOF
EP3040074A4 (en) PHARMACEUTICAL PREPARATION OF INJECTION, AND METHOD OF MANUFACTURING THE SAME
EP2980084A4 (en) PROCESS FOR PRODUCING GLYCOLIDE
HK1224221A1 (zh) 含有托格列淨的固體製劑及其生產方法
HK1202857A1 (en) Benzodioxole derivative and preparation method and use thereof
EP2982843A4 (en) PROTECTIVE SCREEN AND METHOD FOR PRODUCING PROTECTIVE SCREEN
IL239958A0 (en) A chewable preparation for oral care and a process for its preparation
HK1206329A1 (en) Phenol derivative, method of preparing same, and pharmaceutical application of same
EP2952519A4 (en) PROTOPANOXADIOL DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF
HUP1300033A2 (en) Improved process for producing pharmaceutical agent and intermediate
PL3069610T3 (pl) Ko-kryształ i sposób jego wytwarzania
EP3051131A4 (en) COMPRESSOR AND METHOD FOR PRODUCING A COMPRESSOR
EP2837624A4 (en) 4-SUBSTITUTE-2-HYDROXYLMORPHOLIN-3-ON AND METHOD OF MANUFACTURING THEREOF
PL3062628T3 (pl) Ulepszone gumy do żucia i sposoby ich wytwarzania
EP3061825A4 (en) Method for producing megakaryocytes and platelets

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210414